Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00726167 · ClinicalTrials.gov registry record
Serum Procalcitonin Study in the Management of Ventilated Patients
A clinical trial, sponsored by University of Missouri-Columbia.
- Completed
- Registry status
- 29
- Enrollment target
NCT00726167: Completed study, sponsored by University of Missouri-Columbia.
NCT00726167 is a clinical trial that has completed, run by University of Missouri-Columbia. The registered enrollment target is 29 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00726167 has completed, sponsored by University of Missouri-Columbia.
- COMPLETED
- Registry status
- 29 participants
- Enrollment target
Study Summary
The purpose of this study is to test a new method for diagnosing and monitoring Ventilator-Associated Pneumonia, which is a major killer among ICU patients. The method requires analysis of a small amount of the patient's blood for concentration of a hormone called Procalcitonin.
Interventions
- DEVICE Procalcitonin Level
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2008-09 |
| Est. Completion | 2014-08 |
What the finished NCT00726167 record still lists
NCT00726167 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 29 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Procalcitonin Level is the first listed.
NCT00726167 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00726167 about?
NCT00726167 is a clinical study titled "Serum Procalcitonin Study in the Management of Ventilated Patients". The purpose of this study is to test a new method for diagnosing and monitoring Ventilator-Associated Pneumonia, which is a major killer among ICU patients. The method requires analysis of a small amount of the patient's blood for concentration of a hormone called Procalcitonin.
What is the current status of trial NCT00726167?
This trial is currently completed. The enrollment target is 29 participants. The study started on 2008-09. Estimated completion is 2014-08.
What interventions are being tested in trial NCT00726167?
The interventions under investigation include: Procalcitonin Level (DEVICE).
Who is sponsoring clinical trial NCT00726167?
This trial is sponsored by University of Missouri-Columbia, which has 291 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02429557 · 29 participants · Phase 1
Hemodynamic Mechanisms of Abdominal Compression in the Treatment of Orthostatic Hypotension in Autonomic Failure
- NCT02568878 · 29 participants · Phase 3
Creatine for Depressed Male and Female Methamphetamine Users
- NCT03014401 · 29 participants · NA
The Effect of Adipose-Derived Stem Cells for Knee Osteoarthritis
- NCT03128996 · 29 participants · Phase 1
Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia